P Furmanski

Author PubWeight™ 52.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Expression of differentiated functions in mouse neuroblastoma mediated by dibutyryl-cyclic adenosine monophosphate. Nature 1971 1.87
2 A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods 1987 1.52
3 Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 1995 1.48
4 Prognostic value of estrogen receptor determinations in patients with breast cancer. Cancer Res 1978 1.29
5 In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood 1989 1.09
6 Growth of Escherichia coli on fatty acids: requirement for coenzyme A transferase activity. Biochem Biophys Res Commun 1968 1.08
7 The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update. Cancer 1980 1.08
8 Inhibition by 2',3'-dideoxythymidine of retroviral infection of mouse and human cells. Cancer Lett 1980 1.08
9 Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994 1.05
10 Growth of human mammary epithelial cells on collagen gel surfaces. Cancer Res 1981 0.99
11 Cell surface interactions with concanavalin A. Location of bound radiolabeled lectin. Exp Cell Res 1974 0.97
12 Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors. Cancer Res 1988 0.94
13 Concanavalin A-mediated hemadsorption by normal and malignant human mammary epithelial cells. Cancer Res 1978 0.94
14 Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture. J Cell Biol 1980 0.93
15 Growth of normal and malignant human mammary epithelial cells in culture. J Natl Cancer Inst 1979 0.92
16 Selection of mutants constitutive for several glyoxylate condensing enzymes during growth on valeric acid. Biochim Biophys Acta 1967 0.91
17 Infection of macrophages with Friend virus: relationship to the spontaneous regression of viral erythroleukemia. Cell 1979 0.90
18 Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression. J Immunol 1978 0.90
19 High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier. Biochim Biophys Acta 1986 0.88
20 Normal human mammary cells in culture: evidence for oncornavirus-like particles. J Natl Cancer Inst 1974 0.87
21 Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 1999 0.87
22 The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation. Magn Reson Imaging 1986 0.86
23 1H-NMR relaxation times and water compartmentalization in experimental tumor models. Magn Reson Imaging 1986 0.86
24 Effects of dimethylsulfoxide on expression of differentiated functions in mouse neuroblastoma. J Natl Cancer Inst 1972 0.86
25 Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes. Cancer Res 1986 0.86
26 Prognostic value of concanavalin A reactivity of primary human breast cancer cells. Cancer Res 1981 0.86
27 A murine model system for the study of the human leukemia-associated inhibitory activity. Blood 1980 0.86
28 Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells. J Natl Cancer Inst 1978 0.85
29 Function of the glyoxylate-condensing enzymes. I. Growth of Escherichia coli on n-valeric acid. J Bacteriol 1967 0.85
30 Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity. Exp Hematol 1991 0.84
31 Interleukin-1 alpha-induced tumour pathophysiologies can be exploited with bioreductive alkylating agents. Int J Radiat Biol 1991 0.84
32 Identification and isolation of the major core protein from the oncornavirus-like particle in human milk. Cancer Res 1976 0.83
33 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors. Cancer Res 1989 0.82
34 Effect of the extracellular matrix on plasminogen activator isozyme activities of human mammary epithelial cells in culture. Mol Cell Biol 1983 0.81
35 Spontaneous regression of friend virus induced leukemia: coinfection with regressing and conventional strains of virus. Science 1975 0.81
36 Cell fusion in tumor development and progression: occurrence of cell fusion in primary methylcholanthrene-induced tumorigenesis. Int J Cancer 1989 0.81
37 In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications. Blood 1988 0.80
38 In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). Exp Hematol 1990 0.80
39 Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice. Leukemia 1989 0.79
40 Inhibition of normal erythropoiesis in mice with Friend virus induced erythroleukemia. Exp Hematol 1982 0.79
41 Differentiation of normal human mammary epithelial cells in culture: an ultrastructural study. Am J Anat 1976 0.79
42 Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int J Radiat Oncol Biol Phys 1993 0.79
43 Absence of tumorigenicity in athymic mice by normal human epidermal keratinocytes after culture in serum-free medium. Cancer Lett 1992 0.79
44 Effects of thymectomy and antithymocyte serum on spontaneous regression of Friend virus-induced erythroleukemia. J Natl Cancer Inst 1976 0.79
45 Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer. Clin Cancer Res 1998 0.79
46 Iron-induced conformational change in human lactoferrin: demonstration by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analysis of effects of iron binding to the N and C lobes of the molecule. Electrophoresis 1994 0.79
47 Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor. J Natl Cancer Inst 1991 0.78
48 Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors. Cancer Lett 1990 0.78
49 Mechanism of macrophage reversal of Friend erythroleukemia: macrophage regulation of normal and leukemic erythropoiesis. Cancer Res 1986 0.78
50 Cell surface interactions with concanavalin A: determination by microhemadsorption. Proc Soc Exp Biol Med 1972 0.77
51 Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study. J Nucl Med 1993 0.77
52 Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper murine leukemia virus component. J Exp Med 1977 0.77
53 Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole. Cancer Res 1990 0.77
54 Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice. Cancer Chemother Pharmacol 1993 0.77
55 Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model. Cancer Res 1994 0.77
56 Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha. Cancer Res 1991 0.76
57 Spontaneous regression of Friend virus-induced erythroleukemia. VI. Structural and antigenic differences between the regressing and conventional strains of virus. J Virol 1980 0.75
58 The effect of adrenalectomy and dexamethasone on interleukin-1 alpha induced responses in RIF-1 tumours. Br J Cancer 1990 0.75
59 Inhibition of CFU-E colony formation by resident peritoneal macrophages from hybrids of BALB/c mice. J Leukoc Biol 1984 0.75
60 The role of interferon in the spontaneous regression of Friend virus induced leukemia. Proc Soc Exp Biol Med 1975 0.75
61 Induction of lactoferrin expression in murine ES cells by retinoic acid and estrogen. Exp Cell Res 1998 0.75
62 Penetration of cells into Millipore diffusion chambers. Exp Cell Res 1977 0.75
63 The effect of continuous infusion IL-1 alpha on carboplatin-induced thrombocytopenia and anti-tumor activity in RIF-1 tumor bearing mice. Oncol Rep 2011 0.75
64 Stimulation of normal erythropoiesis in vitro by macrophages from erythroleukemic mice. J Natl Cancer Inst 1984 0.75
65 Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugs. In Vivo 1994 0.75
66 Results of a community-based breast cancer screening program. Prog Clin Biol Res 1989 0.75
67 Induction of permanent regression of Friend virus (FV) leukemia by adoptive transfer of T helper and not T cytotoxic cells. Leuk Res 1992 0.75
68 Spontaneous regression of Friend murine leukemia virus-induced erythroleukemia. V. Cell-mediated antivirus immunity in mice undergoing erythroleukemia regression and in leukemic mice. J Natl Cancer Inst 1980 0.75
69 Iron binding to human lactoferrin alters reactivity of the protein with plant lectins. Biochem Biophys Res Commun 1993 0.75
70 SIM and SIM.R mice are histoincompatible. Virology 1978 0.75
71 Spontaneous regression of Friend virus-induced erythroleukemia IX. Role of complement in leukemia regression. Leuk Res 1982 0.75
72 Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody. Adv Exp Med Biol 1994 0.75
73 An analysis of factors associated with non-compliance with follow-up recommendations after a positive fecal occult blood test. Prog Clin Biol Res 1989 0.75
74 Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts. Cancer Res 2001 0.75
75 In vivo effects of recombinant human and murine interleukin-1 alpha (IL-1 alpha) on murine hematopoiesis. In Vivo 1991 0.75
76 Spontaneous regression of Friend virus-induced erythroleukemia. II. regression of Friend murine leukemia virus-induced lymphocytic leukemia. J Natl Cancer Inst 1977 0.75
77 Effect of high-dose, fractionated local irradiation on MNU-induced carcinogenesis in the rat mammary gland. Carcinogenesis 1995 0.75
78 Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system. Cancer Res 1990 0.75
79 Infection of haematopoietic stem cells in mice with Friend virus induced erythroleukaemia. Cell Tissue Kinet 1986 0.75
80 An ultrastructural study of normal human mammary epithelial cells in culture. Am J Anat 1975 0.75
81 Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignancies. J Immunother 1998 0.75
82 Spontaneous regression of Friend murine leukemia virus-induced erythroleukemia. IV. Effects of radiation and athymia on leukemia regression in mice. J Natl Cancer Inst 1979 0.75
83 Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts. Cancer Res 1990 0.75
84 Spontaneous regression of Friend-virus-induced erythroleukemia. VII. The genetic control of regression. Int J Cancer 1981 0.75
85 The etiology of breast cancer. Curr Top Mol Endocrinol 1976 0.75
86 Spontaneous regression of Friend virus-induced erythroleukemia-VIII. Humoral immune reactivity in regressed and leukemic mice. Leuk Res 1981 0.75
87 In vitro studies on the mechanism of action of hepsulfam in chronic myelogenous leukemia patients. Cancer Res 1990 0.75
88 Effects of inhibitors and activators of protein kinase C on late erythroid progenitor (CFU-e) colony formation in vitro. Int J Cell Cloning 1989 0.75
89 Results of a preliminary "blind" study on the presence of the human tumor nucleolar antigen in breast carcinomas, benign breast tumors, and normal breast tissues. Clin Immunol Immunopathol 1981 0.75
90 Differential effect in vitro of tumor necrosis factor-alpha (TNF) on normal and virus-infected erythroid progenitors from Friend virus (FVA)-infected mice. Exp Hematol 1992 0.75
91 Effect of C-reactive protein on granulocyte-macrophage progenitor cells. J Lab Clin Med 1982 0.75